Table 1.

The association of TXNDC17 expression with clinicopathological parameters and BECN1 expression

Variable	N	TXNDC17 expression	P value
		Low	High
Age(years)				0.192
<50	66	41	25
≥50	91	47	44
FIGO stage				0.076
I/II	33	23	10
III/IV	124	65	59
Tumor grade				0.615
I/II	58	31	27
III	99	57	42
Ascitic fluid volume (mL)				0.066
<500	99	61	38
≥500	58	27	31
Serum CA125(U/mL)				0.017*
<500	76	50	26
≥500	81	38	43
Primary surgery				0.010*
Optimal	114	71	43
Suboptimal	43	17	26
Chemosensitivity				0.007**
Sensitive	117	75	42
Resistant	34	13	21
BECN1 expression				0.000**
Low	99	77	22
High	58	11	47

* P < 0.05, ** P < 0.01